Evidence map›Paper›PMID 40528450›Full record

ReviewNanomedicine (London, England)2025

Applications of virus-like particles in the prevention of protozoan parasite infection.

Ki Back Chu, Fu-Shi Quan

Abstract readReview
In one paragraph

Review in Nanomedicine (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Veterinary sciences · 2026
    Review
  2. Protection AgainstPharmaceutics · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ki Back ChuDepartment of Parasitology, Inje University College of Medicine, Busan, Republic of Korea.
Fu-Shi QuanDepartment of Medical Zoology, School of Medicine, Kyung Hee University, Seoul, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vaccination is widely regarded as the most effective control measure for disease prevention, as demonstrated by its success against numerous infectious diseases. However, the development of vaccines to prevent parasitic diseases in humans remains a significant challenge. Despite decades of effort, malaria continues to remain as the leading cause of death among parasitic diseases in tropical regions, while chronic infections caused by

Indexed as

Protozoan InfectionsProtozoan VaccinesVaccines, Virus-Like ParticleAnimalsHumansLeishmaniaPlasmodiumToxoplasmaProtozoan VaccinesVaccines, Virus-Like ParticleLeishmaniasismalariaprotozoan parasitestoxoplasmosisvaccinevirus-like particle

Identifiers

PMID40528450
PMCPMC12233723

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.